[Home] [Headlines] [Latest Articles] [Latest Comments] [Post] [Sign-in] [Mail] [Setup] [Help]
Status: Not Logged In; Sign In
Health See other Health Articles Title: Common Medications For ADHD Linked To Increased Risk Of Glaucoma Authored by Marina Zhang via The Epoch Times Common drugs prescribed to treat attention-deficit/hyperactivity disorder (ADHD) are associated with an increased risk of glaucoma, a recent Canadian study found. (joel bubble ben/Shutterstock) Glaucoma is a progressive eye disease that causes vision loss. Angle-closure glaucoma is a subtype that contraindicates with popular ADHD drugs. Dr. Rami Darwich, an ophthalmology resident and the studys lead author, told The Epoch Times that the study does not establish causation but rather highlights an elevated risk of glaucoma. Common ADHD Drugs Many popular ADHD drugs are sympathomimetic drugs, meaning they activate the sympathetic nervous system to help people focus. However, their downstream effects can inadvertently contribute to elevated eye pressure. High eye pressure is a significant risk factor for glaucoma, though Dr. Darwich added that some glaucoma has developed even without significant pressure changes in recent years. Common ADHD drugs include sympathetic stimulants such as methylphenidate and amphetamines. These are often first-line treatments for people with ADHD due to their greater efficacy. Psychostimulants are effective for about 70 percent of ADHD patients. Non-sympathomimetic drugs, such as atomoxetine, increase chemicals in the brain to help the brain work and concentrate. Atomoxetine is usually prescribed when the patient is unresponsive to first-line drugs. The study authors followed 240,257 newly prescribed subjects who took either methylphenidate, amphetamines, atomoxetine, or a combination of these drugs for a year or more. Study participants were then followed and compared to people who had not taken ADHD drugs to determine glaucoma risks. People who took amphetamines and atomoxetine had a higher risk of angle-closure glaucoma (ACG), while people who took methylphenidate had a higher risk of open-angle glaucoma (OAG) Post Comment Private Reply Ignore Thread
|
||
[Home]
[Headlines]
[Latest Articles]
[Latest Comments]
[Post]
[Sign-in]
[Mail]
[Setup]
[Help]
|